Short-term treatment with indinavir fails to reduce the glucose requirement in a patient with malignant insulinoma.
Schütt
M
M
Aries
S P
SP
Rosenfeldt
M
M
Peters
A
A
Klein
H H
HH
D000368:Aged; D001786:Blood Glucose / Q000187:drug effects; D005260:Female; D005947:Glucose / Q000627:therapeutic use; D017320:HIV Protease Inhibitors / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D007003:Hypoglycemia / Q000097:blood / Q000188:drug therapy / Q000209:etiology*; D019469:Indinavir / Q000494:pharmacology / Q000627:therapeutic use*; D007262:Infusions, Intravenous; D007333:Insulin Resistance; D007340:Insulinoma / Q000150:complications* / Q000188:drug therapy*; D010190:Pancreatic Neoplasms / Q000150:complications* / Q000188:drug therapy*; D012008:Recurrence; D013997:Time Factors; D016896:Treatment Outcome
D001786:Blood Glucose; D017320:HIV Protease Inhibitors; D019469:Indinavir; D005947:Glucose